Evidence map›Paper›PMID 31878276›Full record

ArticleCells2019

Distinct Role of CD11b

Sheng-Yan Wu, Chi-Shiun Chiang

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Structure-guided design and engineering of a biparatopic antibody targeting CCR2 in triple negative breast cancer.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sheng-Yan WuDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, 101 Sec. 2, Kuang-Fu Road, Hsinchu 30013, Taiwan.
Chi-Shiun ChiangDepartment of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, 101 Sec. 2, Kuang-Fu Road, Hsinchu 30013, Taiwan.
National Tsing Hua University · TW

Funding

Frontier Research Center within the framework of the Higher Education Sprout Project by the Ministry of Education MOE 107QR001I5Ministry of Science and Technology MOST 107-2314-B-007-003-MY3National Health Research Institutes NHRI-EX107-10514BI
6 · The paper itself

Abstract

Myeloid-derived cells have been implicated as playing essential roles in cancer therapy, particularly in cancer immunotherapy. Most studies have focused on either CD11b

Indexed as

AnimalsAstrocytomaBrain NeoplasmsCD11b AntigenCell DifferentiationCell ProliferationDiphtheria ToxinDisease Models, AnimalDisease ProgressionGanciclovirMiceMice, Inbred C57BLMice, TransgenicMonocytesMyeloid CellsMyeloid-Derived Suppressor CellsCD11b AntigenDiphtheria ToxinGanciclovirITGAM protein, humanbrain tumormyeloid cellstumor-associated macrophages

Identifiers

PMID31878276
PMCPMC7016541
OpenAlexW2998397349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.